Evidence map›Paper›PMID 42015972›Full record

ArticleCase reports in gastrointestinal medicine2026

Markedly Elevated CA 19-9 in ANA/ASMA-Negative IgG4-Related Autoimmune Hepatitis With Concomitant Pancreatitis: A Case Report.

Hunter Scott, Samuel Reiss

Abstract read
In one paragraph

Article in Case reports in gastrointestinal medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hunter ScottDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org.ORCID https://orcid.org/0000-0001-8116-5437
Samuel ReissDepartment of Internal Medicine, Cleveland Clinic, Cleveland, Ohio, USA, clevelandclinic.org.ORCID https://orcid.org/0009-0003-7197-3803

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: IgG4-related disease (IgG4-RD) can involve the liver and pancreas and may present without conventional autoimmune hepatitis (AIH) autoantibodies, creating diagnostic delay unless IgG4 testing and tissue immunostaining are pursued. We describe an older man with acute hepatocellular injury and marked hyperbilirubinemia who was negative for antinuclear (ANA) and antismooth muscle (ASMA) antibodies but had markedly elevated serum IgG4 and IgG4-positive plasma cell infiltration on liver biopsy, consistent with IgG4-related autoimmune hepatitis (IgG4-AIH). Case Presentation: A man in his 80s presented with abdominal pain followed by progressive jaundice and pruritus, with acute hepatocellular injury and hyperbilirubinemia. Evaluation showed negative ANA and ASMA, elevated total IgG (2166 mg/dL) and IgG4 (442.5 mg/dL), CA 19-9 1268 U/mL, and CT/MRCP findings consistent with pancreatitis without biliary obstruction or mass. HFE analysis showed compound heterozygosity. Liver biopsy demonstrated interface hepatitis with plasma cell-rich inflammation and increased IgG4-positive plasma cells (up to 58 per high-power field), supporting IgG4-AIH. Minimal iron deposition on biopsy favored inflammation-related iron study abnormalities rather than primary hemochromatosis. The pancreatic findings were most consistent with probable Type 1 autoimmune pancreatitis. Prednisone 40 mg daily led to improvement, with normalization of transaminases and total bilirubin by Day 57 (approximately 8 weeks) in available follow-up testing. Conclusion: IgG4-AIH is diagnostically challenging, particularly in seronegative presentations. Unexpectedly high CA 19-9 may be seen in IgG4-RD, which may mimic malignancy. In atypical presentations such as those occurring in older adults without conventional antibody positivity or with concurrent pancreatitis on imaging, clinicians should promptly consider early biopsy with immunostaining to avoid diagnostic delay and enable timely steroid treatment.

Indexed as

autoimmune hepatitisautoimmune pancreatitisCA 19-9case reportIgG4-related disease

Identifiers

PMID42015972
PMCPMC13092795

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.